These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27344317)

  • 21. Cerebral white matter lesions in patients with cirrhosis - causative for hepatic encephalopathy or bystanders?
    Pflugrad H; Bronzlik P; Raab P; Tryc AB; Goldbecker A; Barg-Hock H; Strassburg CP; Ding XQ; Lanfermann H; Weissenborn K
    Liver Int; 2015 Jul; 35(7):1816-23. PubMed ID: 25546380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sub-clinical hepatic encephalopathy in cirrhotic patients is not aggravated by sedation with propofol compared to midazolam: a randomized controlled study.
    Khamaysi I; William N; Olga A; Alex I; Vladimir M; Kamal D; Nimer A
    J Hepatol; 2011 Jan; 54(1):72-7. PubMed ID: 20934771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive deficits in patients with hepatic cirrhosis and in liver transplant recipients.
    Pantiga C; Rodrigo LR; Cuesta M; Lopez L; Arias JL
    J Neuropsychiatry Clin Neurosci; 2003; 15(1):84-9. PubMed ID: 12556577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency of poor quality of life and predictors of health related quality of life in cirrhosis at a tertiary care hospital Pakistan.
    Parkash O; Iqbal R; Jafri F; Azam I; Jafri W
    BMC Res Notes; 2012 Aug; 5():446. PubMed ID: 22905795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver transplantation significantly improves global functioning and cerebral processing.
    Ahluwalia V; Wade JB; White MB; Gilles HS; Heuman DM; Fuchs M; Gavis EA; Fagan A; Tinsley F; Ganapathy D; Thacker LR; Sterling RK; Stravitz RT; Puri P; Sanyal AJ; Siddiqui MS; Matherly S; Luketic V; Steinberg J; Moeller FG; Bajaj JS
    Liver Transpl; 2016 Oct; 22(10):1379-90. PubMed ID: 27339647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement of sleep architecture parameters in cirrhotic patients with recurrent hepatic encephalopathy with the use of rifaximin.
    Bruyneel M; Sersté T; Libert W; van den Broecke S; Ameye L; Dachy B; Mulkay JP; Moreno C; Gustot T
    Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):302-308. PubMed ID: 27977438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depression, anxiety and alexithymia symptoms are major determinants of health related quality of life (HRQoL) in cirrhotic patients.
    Nardelli S; Pentassuglio I; Pasquale C; Ridola L; Moscucci F; Merli M; Mina C; Marianetti M; Fratino M; Izzo C; Merkel C; Riggio O
    Metab Brain Dis; 2013 Jun; 28(2):239-43. PubMed ID: 23296469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy.
    Prasad S; Dhiman RK; Duseja A; Chawla YK; Sharma A; Agarwal R
    Hepatology; 2007 Mar; 45(3):549-59. PubMed ID: 17326150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Predictors for Poor Quality of Life in Patients With Covert Hepatic Encephalopathy.
    Labenz C; Toenges G; Schattenberg JM; Nagel M; Sprinzl MF; Nguyen-Tat M; Zimmermann T; Huber Y; Marquardt JU; Galle PR; Wörns MA
    J Clin Gastroenterol; 2019 Aug; 53(7):e303-e307. PubMed ID: 30439761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a three-factor neuropsychological approach for detecting minimal hepatic encephalopathy.
    Stewart CA; Enders FT; Schneider N; Felmlee-Devine D; Kamath PS; Smith GE
    Liver Int; 2010 Jul; 30(6):841-9. PubMed ID: 20412441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled study.
    Sanyal A; Younossi ZM; Bass NM; Mullen KD; Poordad F; Brown RS; Vemuru RP; Mazen Jamal M; Huang S; Merchant K; Bortey E; Forbes WP
    Aliment Pharmacol Ther; 2011 Oct; 34(8):853-61. PubMed ID: 21848797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality of life in cirrhosis is related to potentially treatable factors.
    Les I; Doval E; Flavià M; Jacas C; Cárdenas G; Esteban R; Guardia J; Córdoba J
    Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):221-7. PubMed ID: 19794311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Falls and cognitive dysfunction impair health-related quality of life in patients with cirrhosis.
    Román E; Córdoba J; Torrens M; Guarner C; Soriano G
    Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):77-84. PubMed ID: 22954704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extrapyramidal signs predict the development of overt hepatic encephalopathy in patients with liver cirrhosis.
    Compañy L; Zapater P; Pérez-Mateo M; Jover R
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):519-25. PubMed ID: 20010298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frailty, Psychoactive Medications, and Cognitive Dysfunction Are Associated With Poor Patient-Reported Outcomes in Cirrhosis.
    Tapper EB; Baki J; Parikh ND; Lok AS
    Hepatology; 2019 Apr; 69(4):1676-1685. PubMed ID: 30382584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new insight into the differences among non-cirrhotic and cirrhotic patients using the liver disease quality of life instrument (LDQOL).
    Dias Teixeira MC; de Fátima Gomes de Sá Ribeiro M; Strauss E
    Ann Hepatol; 2005; 4(4):264-71. PubMed ID: 16432492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychological Burden of Hepatic Encephalopathy on Patients and Caregivers.
    Fabrellas N; Moreira R; Carol M; Cervera M; de Prada G; Perez M; Vazquez E; Sola M; Sancho R; Juanola A; Pose E; Solé C; Graupera I; Solà E; Kamath PS; Ginès P
    Clin Transl Gastroenterol; 2020 Apr; 11(4):e00159. PubMed ID: 32352686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. US valuation of health outcomes measured using the PROMIS-29.
    Craig BM; Reeve BB; Brown PM; Cella D; Hays RD; Lipscomb J; Simon Pickard A; Revicki DA
    Value Health; 2014 Dec; 17(8):846-53. PubMed ID: 25498780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic Encephalopathy Is Associated with Persistent Learning Impairments Despite Adequate Medical Treatment: A Multicenter, International Study.
    Nardelli S; Allampati S; Riggio O; Mullen KD; Prakash R; Gioia S; Unser A; White MB; Fagan AC; Wade JB; Farcomeni A; Gavis EA; Bajaj JS
    Dig Dis Sci; 2017 Mar; 62(3):794-800. PubMed ID: 28039670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective comparative study of inhibitory control test and psychometric hepatic encephalopathy score for diagnosis and prognosis of minimal hepatic encephalopathy in cirrhotic patients in the Indian subcontinent.
    Gupta D; Ingle M; Shah K; Phadke A; Sawant P
    J Dig Dis; 2015 Jul; 16(7):400-7. PubMed ID: 25858627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.